Meta-Analyses of the Efficacy and Tolerability of the Tricyclic Antidepressant Lofepramine

@article{Kerihuel1991MetaAnalysesOT,
  title={Meta-Analyses of the Efficacy and Tolerability of the Tricyclic Antidepressant Lofepramine},
  author={Jean Charles Kerihuel and Jean-François Dreyfus and Gary Milton Whitford and E. Merck},
  journal={Journal of International Medical Research},
  year={1991},
  volume={19},
  pages={183 - 201}
}
Lofepramine is a tricyclic antidepressant related to imipramine. Meta-analyses were carried out with respect to efficacy and tolerability by combining outcome and adverse reaction from over 20 controlled trials comparing lofepramine with other tricyclic antidepressants. Lofepramine was at least as effective as the comparators with fewer adverse effects. In particular, the risk/benefit ratio seemed superior to the comparators amitriptyline, imipramine, clomipramine, maprotiline and desipramine. 

Figures and Tables from this paper

A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity

In both analyses the profile of lofepramine, fluoxetine and parxetine were found to be favourable compared to those of amitriptyline and dothiepin, suggesting that the prescription of older tricyclic compounds should be the exception rather than the rule in the pharmacotherapy of depression.

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

This study does not support previous claims of specific adverse effects of fluoxetine on anxiety and suicidality, and there were no differences between the groups, either at baseline or after 6 weeks, in total HRDS score or in subscores for anxiety or suicideality.

Comparative Tolerability Profiles of the Newer versus Older Antidepressants

The availability of new-generation antidepressants increases the likelihood of clinical response with a reduction in unwanted toxicity, and Monoamine oxidase (MAO) inhibitors have also been refined; reversible inhibitors of MAO-type A afford protection against the usually feared hypertensive reaction to indirect sympathomimetic substances.

Meta-analytical studies on new antidepressants.

  • I. Anderson
  • Psychology, Medicine
    British medical bulletin
  • 2001
A systematic search found 108 meta-analyses of the use of antidepressants in depressive disorders of uneven quality and confidence, which limits the confidence in many of the results.

Choice of antidepressants by psychiatrists working with old people

In 1992, 46 consultants in old age psychiatry were asked to list their five most frequently used antidepressants, with reasons for their choices, and to comment on an information set for evaluating

Lessons to be Learnt from Meta-analyses of Newer Versus Older Antidepressants

Meta-analysis is the use of statistical techniques to analyse the findings of many individual analyses (Glass, 1977). It covers all aspects of the review process involving formulating relevant

The effect of low dose lofepramine in depressed elderly patients in general medical wards.

Low dose lofepramine may prove useful in moderately or severely depressed patients treated for only 4 weeks, but is not indicated for mild (GDS 15-18) depression.

Prescribing antidepressants in general practice

A recommended dose of a typical tricyclic antidepressant, amitriptyline, as 125 mg daily is quoted, which is at the higher end of the range of dosages quoted for all tricyClic antidepressants in the British National Formulary, if followed.

Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches.

In this paper, data is presented on how this epileptogenic mechanism can be studied in vitro and the advantages and disadvantages of routine EEG recordings and ambulatory monitoring discussed.

Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches.

In this paper, data is presented on how this epileptogenic mechanism can be studied in vitro and the advantages and disadvantages of routine EEG recordings and ambulatory monitoring discussed.

References

SHOWING 1-10 OF 57 REFERENCES

[Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].

Two random groups of depressed out-patients were treated with either Maprotiline or the new antidepressant Lofepramine, and both drugs produced remarkable improvement globally in total HAM-D score as well as in the symptom clusters.

[Double-blind comparative study on the effects of lofepramine and amitriptyline in depressive outpatients (author's transl)].

Lofepramine, a new tricyclic antidepressant, has in animal studies been shown to have weak anticholinergic effects and a low acute toxicity, and whether these pharmacological properties led to a lower rate of side-effects in depressed patients was investigated.

Does lofepramine have fewer side effects than amitriptyline? Results of a comparative trial.

A double-blind trial with amitriptyline and lofepramine in the treatment of endogenous depression.

The results demonstrate that both substances are effective in the treatment of depression, however, the therapeutical efficacy of Lofepramine is significantly greater than that of Amitriptyline.

The comparative antidepressant value of lofepramine and amitriptyline

Patients with endogenous depression responded, significantly more rapidly lofepramine as measured by Visual analogue Scales and showed a significantly greater degree of clinical improvement after 4 weeks' treatment, as measuredby Golbal Assessment.

Comparative clinical evaluation of lofepramine and imipramine

Patients with a depressive syndrome that normally would have been treated with a tricyclic antidepressant were treated with lofepramine and imipramine in a multicentre, double‐blind clinical trial.

Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Lofepramine is a tricyclic antidepressant that is structurally similar to imipramine and is extensively metabolised to desipramine. In the absence of other major pharmacological effects it appears

A double blind comparison of lofepramine, imipramine and placebo in patients with primary depression

The results of a double blind trial in which 139 patients with primary depression were randomly assigned to either lofepramine (46), imipramine (48), or placebo (45) are discussed.

The Risk-Benefit Assessment of Antidepressant Drugs

It is clear that antidepressants should be prescribed, as their benefits outweigh their risks, and the majority of antidepressant drugs have a similar degree of efficacy, serves to emphasise the importance of making a risk-benefit assessment of each drug.

Comparative clinical evaluation of lofepramine and imipramine

A significant correlation was found between the concentrations of DMI and the noradrenalinauptake inhibitory capacity in the plasma sample and no correlations were found between uptake inhibitorycapacity of plasma samples and the amelioration scores.
...